A Case of Severe Liver Dysfunction Caused by Pentoxifylline Injection
10.3870/j.issn.1004-0781.2025.05.022
- VernacularTitle:己酮可可碱注射液致严重肝功能异常1例
- Author:
Erxia SHI
1
;
Laiyun YUN
;
Zhongyan ZHOU
;
Zhimin JIN
;
Hua ZHEN
Author Information
1. 呼和浩特市第一医院药剂科,呼和浩特 010030
- Publication Type:Journal Article
- Keywords:
Pentoxifylline injection;
Abnormal liver function;
Adverse drug reaction(ADR)
- From:
Herald of Medicine
2025;44(5):811-813
- CountryChina
- Language:Chinese
-
Abstract:
A male patient,51 years old,was diagnosed as follows:① type 2 diabetes mellitus;② grade 2 hypertension(extremely high risk).To improve circulation,the patient was administered pentoxifylline injection 0.2 g mixed with 250 mL of 0.9%sodium chloride injection via an intravenous drip,once daily(qd).After 4 days of treatment,liver function tests showed the following results:alanine aminotransferase(ALT)at 2 390.80 U·L-1,aspartate aminotransferase(AST)at 948.28 U·L-1,and gamma-glutamyltransferase(GGT)at 517.81 U·L-1.It was highly probable that pentoxifylline caused abnormally elevated liver enzymes,with a clear drug-related association.After discontinuing pentoxifylline injection and initiating liver-protecting and en-zyme-lowering treatment,the liver function indicators gradually improved.Enhanced monitoring during the clinical use of pentoxi-fylline is essential to ensure patient safety.